Send us a text

We are back again discussing stereotactic ablative body radiotherapy (SABR) with Dr Harshani Green from the Royal Marsden Hospital.

Join us if :

- You want to hear about the evidence from the FASTRACK II trial using renal SABR

- You are a centre thinking about setting up renal SABR

- You want to hear about the challenges of comparing renal SABR with surgery

Will radiotherapy be able to replace cytoreductive nephrectomy in metastatic renal carcinoma?

We discuss this and more (plus Mike produces a Magic Lamp!)

Enjoy

Send us a text

Join us for Part 1 of our 2 part Simply Oncology podcast with Dr Harshani Green on Stereotactic Ablative Body Radiotherapy (SABR) in Renal Cell Carcinoma.

We discuss the role of high precision radiotherapy treating renal cell carcinoma in those patients where an operation may not be possible.

- We discuss the excellent control rates

- What size of tumour can we treat?

- Will we ever be able to compare Surgery versus SABR for primary renal cell carcinoma cancers?

Send us a text

Surgery in Bladder Cancer Bumper episode!
We talk to Professor Jim Catto about surgery in Bladder Cancer.
🎙️we discuss the GUSTO trial stratifying bladder cancer therapy by molecular subtype
🎙️we look at quality of life and #cystectomy🎙️we look at surgical outcomes from NIAGARA
🎙️we look at peri-operative trials

A bumper Bladder Cancer issue

Send us a text

We welcome back Professor Tom Crosby for another episode on oesophageal cancer.

In the previous episode we focus on the diagnostic pathway. In this episode we look at option in the metastatic and advanced setting.

Send us a text

Join us this week as we hear Professor Tom Crosby share his insights into Oesophageal Cancer.

Few people have been so highly regarded or associated with a cancer type like Tom Crosby and Oesophago-Gastric cancer.

He has set up and run crucial trials, championed equity

Send us a text

Join us for this weeks episode where we discuss the role of PSMA PET scanning in prostate cancer with Dr Amar Challapalli.

PSMA PET scanning in prostate cancer has been a game changer in both diagnosis and treatment.

We explore its role in the post-prostatectomy space.

We look at how PSMA Lutetium offers a new treatment option in prostate cancer.

Send us a text

Join us as we return with another special episode with Professor Alison Birtle.

This time we discuss Upper Tract Urothelial (or ureteric) Cancer.

Alison is an internationally recognised expert in this area and was lead on the POUT adjuvant chemotherapy in ureteric cancer trial.

She describes it as the non-identical twin to bladder urothelial cancer and we discuss the different approaches to this rare cancer.

Described as 'The Queen of Upper Tract Urothelial Cancer' she shares her views on management and areas for development.

Enjoy

Send us a text

🚨May is Bladder Cancer Awareness Month

🎙️What better way to mark this than a Simply Oncology Podcast - Bladder Cancer episode with the irrepressible Professor Alison Birtle. Alison is an internationally recognised expert in bladder and prostate cancer - and is a Simply Oncology Friend of the Show.

🎙️We discuss the recent peri-operative trials such as NIAGARA
🎙️What do surgical adjuvant and neoadjuvant trails now mean for the bladder cancer pathway?

🎙️What is our position on post operative radiotherapy in bladder cancer??